The Ratings Game: Medivation shareholders should be ‘thrilled’ about price of Pfizer deal: analysts

- Home
- TZ Newswire
- Business Features
- ETF's
- Futures
- Options
- Real Estate
- Stocks
- TZ Featured Lists
- TZ Latest News
- TZ Resources
Editorial Archives
Editorial Archives

Published in TZ Latest News 22 August, 2016 by The TZ Newswire Staff

The Ratings Game: Medivation shareholders should be ‘thrilled’ about price of Pfizer deal: analysts

Medivation investors should be “thrilled” that Pfizer agreed to pay what it did to buy the biotechnology company, with the stock trading nearly 20% above its previous record closing price.
read more

See also
- Next Article Daily Digest 8/22 – The Inflation Imperative, Workers’ Hours Are More Unpredictable Than Ever
- Previous Article The New York Post: Colin Powell says Clinton team trying to blame email issues on him
Editorial Calender

August 2016

M T W T F S S

1 2 3 4 5 6 7

8 9 10 11 12 13 14

15 16 17 18 19 20 21

22 23 24 25 26 27 28

29 30 31

« Jul Sep »
Recent Tags

Abnormal Returns Active management Asia Brave New World Business Chart.ly Chicago Board Options Exchange CNBC Commodities and Futures Covestor Day Trading Derivatives Equities Exchange Exchange-traded fund Funds Gawker.com GDP Gold Gold as an investment Gross domestic product High-frequency trading Hong Kong Investing Japan Market maker May 6 2010 flash crash Mutual fund National Association of Home Builders New York Mercantile Exchange Option S&P 500 SEC Standard & Poor Stock Stocks and Bonds Stock trader StockTwits Timothy Sykes Tokyo Trade Twitter U.S. Dollar Index U.S. Securities and Exchange Commission United States dollar

The Traderszone Network

Editorial Archives

Published in TZ Latest News 22 August, 2016 by The TZ Newswire Staff

The Ratings Game: Medivation shareholders should be ‘thrilled’ about price of Pfizer deal: analysts

See also

Editorial Calender

Recent Tags